Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKesson
Dow
AstraZeneca
McKinsey

Last Updated: May 19, 2022

STALEVO 100 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Stalevo 100, and when can generic versions of Stalevo 100 launch?

Stalevo 100 is a drug marketed by Orion Pharma and is included in one NDA.

The generic ingredient in STALEVO 100 is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.

Drug patent expirations by year for STALEVO 100
Recent Clinical Trials for STALEVO 100

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4
Asan Medical CenterN/A
SynAgile CorporationPhase 2

See all STALEVO 100 clinical trials

US Patents and Regulatory Information for STALEVO 100

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma STALEVO 100 carbidopa; entacapone; levodopa TABLET;ORAL 021485-002 Jun 11, 2003 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for STALEVO 100

International Patents for STALEVO 100

See the table below for patents covering STALEVO 100 around the world.

Country Patent Number Title Estimated Expiration
Iceland 3290 See Plans and Pricing
Poland 152642 See Plans and Pricing
Japan 4204783 See Plans and Pricing
Czechoslovakia 8808440 See Plans and Pricing
Japan S63170311 MEDICINAL COMPOSITION CONTAINING CATECHOL DERIVATIVE AS EFFECTIVE COMPONENT See Plans and Pricing
European Patent Office 1189608 PREPARATION PHARMACEUTIQUE A BASE DE LEVODOPA/CARBIDOPA/ENTACAPONE (LEVODOPA/CARBIDOPA/ENTACAPONE PHARMACEUTICAL PREPARATION) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for STALEVO 100

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0426468 C00426468/01 Switzerland See Plans and Pricing FORMER REPRESENTATIVE: BOHEST AG, CH
0426468 CA 2004 00007 Denmark See Plans and Pricing
0426468 0490007-2 Sweden See Plans and Pricing PRODUCT NAME: (E)-2-CYANO-N,N-DIETYL-3-(3,4-DIHYDROXI-5-NITROFENYL)AKRYLAMID; REGSISTRATION NO/DATE: EU/1/03/260/001 20031017
0426468 91071 Luxembourg See Plans and Pricing 91071, EXPIRES: 20151101
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
McKinsey
Medtronic
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.